Objectives: 1. Introduction into saypha® range of HA fillers and their individual rheology.
2. Application and demonstration of saypha® range.
3. Discover how we can embed wellness into our use of dermal fillers in our aesthetic practices.

Introduction: Croma are delighted to introduce saypha® to the European market exclusively launching at IMCAS 2019. Led by Croma Global KOL Dr Rosh, this symposium will explore the revolutionary range, indications and techniques of application of the product. Alongside Dr Rosh; Kimberley Cairns will be exploring the importance of embedding patient welfare, wellness and understanding in the clinic experience curating the most unique experience and most importantly prosperous ethical business and client retention.

Conclusion: Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian family-owned company that specialises in the industrial production of hyaluronic acid syringes for the fields of medical aesthetics, ophthalmology and orthopaedics. Croma’s Managing Director, Andreas Prinz explains “The saypha® brand reflects medical science and evidence based medicine, values that Croma felt committed to at any time. In short, by introducing saypha® we are creating a strong global HA filler brand that stands for comprehensive quality, reliability and medical effectiveness.”

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Croma